The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response
Open accessAbstract
Learning Objectives: After completing this course, the reader will be able to: Explain the effect of hypoxia on resistance to treatment. Describe the causes of tumor hypoxia. Characterize cellular response to hypoxia. Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com Hypoxia is a characteristic feature of locally advanced solid tumors resulting from an imbalance between oxygen (O2) supply and consumption. Major causative factors of tumor hypoxia are abnormal structure and function of the microvessels supplying the tumor, increased diffusion distances between the nutritive blood vessels and the tumor cells, and reduced O2 transport capacity of the blood due to the presence of disease- or treatment-related anemia. Tumor hypoxia is a therapeutic concern since it can reduce the effectiveness of radiotherapy, some O2-dependent cytotoxic agents, and photodynamic therapy. Tumor hypoxia can also negatively impact therapeutic outcome by inducing changes in the proteome and genome of neoplastic cells that further survival and malignant progression by enabling the cells to overcome nutritive deprivation or to escape their hostile environment. The selection and clonal expansion of these favorably altered cells further aggravate tumor hypoxia and support a vicious circle of increasing hypoxia and malignant progression while concurrently promoting the development of more treatment-resistant disease. This pattern of malignant progression, coupled with the demonstration of a relationship between falling hemoglobin level and worsening tumor oxygenation, highlights the need for effective treatment of anemia as one approach for correcting anemic hypoxia in tumors, and in so doing, possibly improving therapeutic response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, the majority of solid tumors are hypoxic due to their rapid growth that outstrips their oxygen supply, exacerbated by the reduced perfusion caused by the aberrant tumor vasculature [4].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [4]
Citations
Cites
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 6×
“Evidence from recent studies suggests that sustained (>6-8 hours) or fluctuating hypoxic stress (pO2 ≤7 mmHg) can lead to alterations (stimulation or inhibition) of gene expression, as well as posttranscriptional and posttranslational modulations that result in changes in the tumor cell proteome (Fig. 6) [ 9-11 , 16].”
BackgroundInfluentialSelf-citationClinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Vaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952
Self-citationThe Role of Hypoxia-Induced Factors in Tumor Progression
Vaupel, P. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-10 · Cited by 827
Self-citationApaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660
Treatment Resistance of Solid Tumors
Vaupel, P., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 558
Self-citationHypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia
Goda, N., Ryan, H. E., Khadivi, B., McNulty, W., Rickert, R. C., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.359-369.2003 · Cited by 520
Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy
VAUPEL, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90210-6 · Cited by 479
Self-citation
Research works printed but not linked: 2
- Schwarz, 1909, Über Desensibilisierung gegen Röntgen- und Radiumstrahlen, Münchener Med Wochenschr, 24, 1
- Zander, 1996, [Oxygen supply and acid-base status in extreme anemia.] Anaesthesiol Intensivmed Notfallmed Schmerzther, 31, 492
Cited by
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
Huang, Y., Ren, J., & Qu, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00672 · Cited by 3,523
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066
“Tumor hypoxia develops due to uncontrollable cell proliferation, altered metabolism, and abnormal tumor blood vessels resulting in reduced transport of oxygen and nutrients.(13) Hypoxia is one of the main features of solid tumors and was shown to correlate with poor prognosis of cancer patients.”
BackgroundLin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
“Hypoxia, which resulted from tumor cells with a status of vigorous metabolism and rapid growth but poorly organized vasculature, is a common feature occurring in the majority of solid tumors [58].”
BackgroundCycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
Metadata
- Authors
- Vaupel, P., & Harrison, L.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Mount Sinai Beth Israel (US)
- Corresponding author
- Vaupel, Peter
- ORCID
- Vaupel, Peter
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 9
- Issue
- S5
- Pages
- 4-9
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2123894943
- Cited by
- 761
- References
- 28
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 34 · 2023: 45 · 2022: 34 · 2021: 50 · 2020: 59 · 2019: 43 · 2018: 38 · 2017: 46 · 2016: 42 · 2015: 44 · 2014: 38 · 2013: 31 · 2012: 40
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tumor microvasculature, anemia, anemic hypoxia, treatment resistance, radiotherapy resistance, photodynamic therapy, hypoxia response, malignant progression, tumor oxygenation, hemoglobin, clonal expansion
- MeSH terms
- Adaptation, Physiological, Anemia, Cell Survival, Cell Transformation, Neoplastic, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Cell Hypoxia, Disease Progression, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. https://app.cochat.ai/papers/10.1634/theoncologist.9-90005-4
- The paper
- Vaupel, P., & Harrison, L. (2004). Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. The Oncologist. https://doi.org/10.1634/theoncologist.9-90005-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.